Company / Depreciation & Amortization
Sana Biotechnology, Inc. Depreciation & Amortization History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$17.4M
FY2024
5-year range
$5.9M / $24.6M
FY2020-FY2024
Trend
-29.3%
vs FY2023
Sector context
#49 of 168
Health Care
What the data says
At $17M, Sana Biotechnology, Inc.'s depreciation & amortization ranks #120 of 168 in the Health Care sector. Increased from $16M to $17M over the past 2 years.
Based on SEC 10-K filings.
$17M in FY2024 with a 5-year CAGR of +57.0%.
Increased from $16M to $17M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +16.2%
- 5-Year CAGR
- +57.0%
- 10-Year CAGR
- -
Sector benchmark
#120 of 168 in Health CareTop 71% of 168This company $17.4M Sector average $212.9M
▼
-91.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +57.0%, indicating consistent growth.
- In FY2024, depreciation & amortization decreased 29.3% year-over-year.
- Ranks #49 out of 168 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $17.4M | -29.3% |
| FY2023 | $24.6M | +57.7% |
| FY2022 | $15.6M | +40.5% |
| FY2021 | $11.1M | +87.5% |
| FY2020 | $5.9M | +224.3% |
| FY2019 | $1.8M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026